Mawi DNA Technologies

Mawi DNA Technologies has established itself as a key enabler in the genomics and diagnostics space with its proprietary iSWAB® collection system. The technology allows for cell release, lysis, and stabilization in a single tube, addressing critical pain points like low DNA recovery, bacterial contamination, and cold-chain logistics. With an FDA-cleared device for respiratory testing and applications spanning human health, forensics, animal science, and agriculture, Mawi is commercializing a versatile platform. The company is ISO 13485 certified, partners with major players like Helix and GenoBank.io, and is positioned to capitalize on the growing demand for decentralized, room-temperature-stable sample collection.

The iSWAB® (integrated Sample With Advanced Buffer) platform: a non-invasive biosample collection system that uses a swab and proprietary buffer to release, lyse, and stabilize cells (DNA/RNA) in a single tube at ambient temperature. It enables extraction-less workflows, minimizes bacterial contamination, and preserves high-quality nucleic acids.

Mawi competes with established biospecimen collection companies like DNA Genotek (part of OraSure), Copan Diagnostics, and Puritan Medical Products. Its key differentiators are its proprietary buffer chemistry for room-temperature stabilization and extraction-less workflow, aiming to displace traditional FTA cards, saliva kits, and viral transport media requiring cold chain.